Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
(3 intermediate revisions by 2 users not shown) | |||
Line 64: | Line 64: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Central obesity]] | * [[Central obesity]] | ||
* Excessive [[sweating]] | * Excessive [[sweating]] | ||
Line 72: | Line 72: | ||
* [[Infertility]] | * [[Infertility]] | ||
* Psychological disturbances | * Psychological disturbances | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
*Positive h/o medications | *Positive h/o medications | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Facial and sphincter [[Muscle|muscles]] are usually spared | * Facial and sphincter [[Muscle|muscles]] are usually spared | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Positive [[ACTH stimulation test]] | * Positive [[ACTH stimulation test]] | ||
* 24-hour urine [[cortisol]] | * 24-hour urine [[cortisol]] | ||
* Low dose [[dexamethasone suppression test]] | * Low dose [[dexamethasone suppression test]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 98: | Line 98: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |−/+([[Rhabdomyolysis]]) | | style="background:#F5F5F5;" align="center" + |−/+([[Rhabdomyolysis]]) | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* N/A | * N/A | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
*Positive h/o medications | *Positive h/o medications | ||
*H/o other medication use | *H/o other medication use | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Tenderness]] | * [[Tenderness]] | ||
* Muscle aches | * Muscle aches | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' Liver enzymes | * '''↑↑''' Liver enzymes | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' | * '''↑↑''' | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Necrosis]] | * [[Necrosis]] | ||
* Degeneration, and regeneration of fibers | * Degeneration, and regeneration of fibers | ||
* Phagocytic infiltration | * Phagocytic infiltration | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 124: | Line 124: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
| style="background:#F5F5F5;" align="center" + |+/− | | style="background:#F5F5F5;" align="center" + | +/− | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Swelling]] | * [[Swelling]] | ||
* Tender | * Tender | ||
* [[Erythema]] and induration | * [[Erythema]] and induration | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Alcohol]] intoxication | * [[Alcohol]] intoxication | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Change in [[mental status]] | * Change in [[mental status]] | ||
* [[Telangiectasias|Telangiectasia]] | * [[Telangiectasias|Telangiectasia]] | ||
* [[Peripheral neuropathy]] | * [[Peripheral neuropathy]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Monspecific and are normal in many patients | * Monspecific and are normal in many patients | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal or '''↑↑''' | * Normal or '''↑↑''' | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 180: | Line 180: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Decreased libido]] | * [[Decreased libido]] | ||
* [[Obesity]]/[[weight gain]] | * [[Obesity]]/[[weight gain]] | ||
Line 193: | Line 193: | ||
* Dorsal fat pad | * Dorsal fat pad | ||
* Abnormal glucose tolerance | * Abnormal glucose tolerance | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* N/A | * N/A | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Facial and sphincter [[muscles]] are usually spared | * Facial and sphincter [[muscles]] are usually spared | ||
* [[Overweight]] | * [[Overweight]] | ||
Line 202: | Line 202: | ||
* [[Hypertension|HTN]] | * [[Hypertension|HTN]] | ||
* [[Hyperpigmentation]] | * [[Hyperpigmentation]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Positive [[ACTH stimulation test]] | * Positive [[ACTH stimulation test]] | ||
* 24-hour urine [[cortisol]] | * 24-hour urine [[cortisol]] | ||
* Low dose [[Dexamethasone suppression test|dexamethasone <nowiki/>suppression test]] | * Low dose [[Dexamethasone suppression test|dexamethasone <nowiki/>suppression test]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Atrophy of type 2 muscle fibers, especially type 2B | * Atrophy of type 2 muscle fibers, especially type 2B | ||
|Normal | | style="background:#F5F5F5;" align="left" + |Normal | ||
|- | |- | ||
! style="background:#DCDCDC;" align="center" + |[[Adrenal insufficiency]]<ref name="pmid30656022">{{cite journal |vauthors=Ruff RL, Weissmann J |title=Endocrine myopathies |journal=Neurol Clin |volume=6 |issue=3 |pages=575–92 |date=August 1988 |pmid=3065602 |doi= |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Adrenal insufficiency]]<ref name="pmid30656022">{{cite journal |vauthors=Ruff RL, Weissmann J |title=Endocrine myopathies |journal=Neurol Clin |volume=6 |issue=3 |pages=575–92 |date=August 1988 |pmid=3065602 |doi= |url=}}</ref> | ||
Line 223: | Line 223: | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Signs of [[glucocorticoid]], [[mineralocorticoid]], and, [[androgen]] deficiency | * Signs of [[glucocorticoid]], [[mineralocorticoid]], and, [[androgen]] deficiency | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Signs of [[postural hypotension]] | * Signs of [[postural hypotension]] | ||
* History of [[tuberculosis]] | * History of [[tuberculosis]] | ||
* History of [[malignancy]] | * History of [[malignancy]] | ||
* History of other [[autoimmune disease]] | * History of other [[autoimmune disease]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Hypotension]] | * [[Hypotension]] | ||
* [[Hyperpigmentation]] | * [[Hyperpigmentation]] | ||
* Auricular−cartilage calcification | * Auricular−cartilage calcification | ||
* [[Vitiligo]] | * [[Vitiligo]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Electrolyte abnormalities]] | * [[Electrolyte abnormalities]] | ||
* [[Hypoglycemia]] | * [[Hypoglycemia]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 262: | Line 258: | ||
[[Rhabdomyolysis]] | [[Rhabdomyolysis]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Palpitations]] | * [[Palpitations]] | ||
* [[Hypertension]] | * [[Hypertension]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Episodes of [[Palpation|increased heart beats]] | * Episodes of [[Palpation|increased heart beats]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Hyperpigmentation]] | * [[Hyperpigmentation]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Hypokalemia]] | * [[Hypokalemia]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 289: | Line 285: | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Signs of [[hyperthyroidism]] | * Signs of [[hyperthyroidism]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* H/o of [[weight loss]] | * H/o of [[weight loss]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Sweating]] | * [[Sweating]] | ||
* [[Tremor]] | * [[Tremor]] | ||
* Neck swelling | * Neck swelling | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Decreased [[TSH]] | * Decreased [[TSH]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' | * '''↑↑''' | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Non specific | * Non specific | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Myotonic]] | * [[Myotonic]] | ||
|- | |- | ||
Line 317: | Line 313: | ||
| style="background:#F5F5F5;" align="center" + | + | | style="background:#F5F5F5;" align="center" + | + | ||
| style="background:#F5F5F5;" align="center" + | + [[Rhabdomyolysis MRI|Rhabdomyolysis]] | | style="background:#F5F5F5;" align="center" + | + [[Rhabdomyolysis MRI|Rhabdomyolysis]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Signs of [[hypothyroidism]] | * Signs of [[hypothyroidism]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* H/o [[weight gain]] | * H/o [[weight gain]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Myxedema|Myxoedema]] | * [[Myxedema|Myxoedema]] | ||
* Muscle pseudohypertrophy | * Muscle pseudohypertrophy | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Increased [[TSH]] | * Increased [[TSH]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' | * '''↑↑''' | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Nonspecific | * Nonspecific | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 344: | Line 340: | ||
| style="background:#F5F5F5;" align="center" + |− | | style="background:#F5F5F5;" align="center" + |− | ||
| style="background:#F5F5F5;" align="center" + | − | | style="background:#F5F5F5;" align="center" + | − | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Cramps]] | * [[Cramps]] | ||
* Sudden onset of [[pain]] | * Sudden onset of [[pain]] | ||
* Anterior thigh [[muscles]] are most commonly involved | * Anterior thigh [[muscles]] are most commonly involved | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* H/O long standing [[diabetes]] | * H/O long standing [[diabetes]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Swelling]] | * [[Swelling]] | ||
* [[Tenderness]] | * [[Tenderness]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Elevated [[ESR]] | * Elevated [[ESR]] | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Necrosis]] | * [[Necrosis]] | ||
* [[Edema]] | * [[Edema]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |- | ||
Line 386: | Line 381: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Electromyogram | ||
|- | |- | ||
! rowspan=" | ! rowspan="6" style="background:#DCDCDC;" align="center" + |Inflammatory/ Rheumatologic | ||
! style="background:#DCDCDC;" align="center" + |[[Dermatomyositis]]<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Dermatomyositis]]<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
| style="background:#F5F5F5;" align="center" + |40s−50s<br>Can affect children | | style="background:#F5F5F5;" align="center" + |40s−50s<br>Can affect children | ||
Line 398: | Line 393: | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | ||
| style="background:#F5F5F5;" align="center" + | − | | style="background:#F5F5F5;" align="center" + | − | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Rash]] | * [[Rash]] | ||
* [[Dyspnea]] | * [[Dyspnea]] | ||
* [[Weight loss]] | * [[Weight loss]] | ||
* [[Cough]] | * [[Cough]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* [[Viral infections]] | * [[Viral infections]] | ||
* [[Cancer]] | * [[Cancer]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Heliotrope rash on face and hands | * Heliotrope rash on face and hands | ||
* [[Telangiectasia]] | * [[Telangiectasia]] | ||
Line 412: | Line 407: | ||
* Mechanic's hands | * Mechanic's hands | ||
* [[Gottron's papules|Gottron's sign]] ( violaceous scaly eruption ) | * [[Gottron's papules|Gottron's sign]] ( violaceous scaly eruption ) | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' [[Erythrocyte sedimentation rate|ESR]] | * '''↑↑''' [[Erythrocyte sedimentation rate|ESR]] | ||
* '''↑↑''' [[C-reactive protein|CRP]] | * '''↑↑''' [[C-reactive protein|CRP]] | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* '''↑↑''' | * '''↑↑''' | ||
| | | style="background:#F5F5F5;" align="left" + | | ||
* Perimysial mononuclear infiltrate | * Perimysial mononuclear infiltrate | ||
| rowspan="2" | | | rowspan="2" style="background:#F5F5F5;" align="left" + | | ||
* [[Myopathic]] | * [[Myopathic]] | ||
|- | |- | ||
Line 534: | Line 529: | ||
| style="background:#F5F5F5;" align="left" + | | | style="background:#F5F5F5;" align="left" + | | ||
* Normal | * Normal | ||
|- | |||
| style="background:#DCDCDC;" align="center" + |Necrotizing autoimmune myopathy | |||
| style="background:#F5F5F5;" align="center" + |30-70 | |||
| style="background:#F5F5F5;" align="center" + |Proximal<br>&<br>distal | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="center" + | | |||
| style="background:#F5F5F5;" align="left" + | | |||
| style="background:#F5F5F5;" align="left" + | | |||
| style="background:#F5F5F5;" align="left" + | | |||
| style="background:#F5F5F5;" align="left" + | | |||
* Anti-SRP | |||
* Anti-HMGCoAR autoantibodies | |||
| style="background:#F5F5F5;" align="left" + | | |||
* '''↑↑''' | |||
| style="background:#F5F5F5;" align="left" + | | |||
| style="background:#F5F5F5;" align="left" + | | |||
|- | |- | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Organ system | ||
Line 764: | Line 781: | ||
! style="background:#DCDCDC;" align="center" + |[[Influenza]]<ref name="pmid6687269">{{cite journal |vauthors=Bove KE, Hilton PK, Partin J, Farrell MK |title=Morphology of acute myopathy associated with influenza B infection |journal=Pediatr Pathol |volume=1 |issue=1 |pages=51–66 |date=1983 |pmid=6687269 |doi= |url=}}</ref> | ! style="background:#DCDCDC;" align="center" + |[[Influenza]]<ref name="pmid6687269">{{cite journal |vauthors=Bove KE, Hilton PK, Partin J, Farrell MK |title=Morphology of acute myopathy associated with influenza B infection |journal=Pediatr Pathol |volume=1 |issue=1 |pages=51–66 |date=1983 |pmid=6687269 |doi= |url=}}</ref> | ||
| style="background:#F5F5F5;" align="center" + |Variable | | style="background:#F5F5F5;" align="center" + |Variable | ||
| style="background:#F5F5F5;" align="center" + | style="background:#F5F5F5;" align="center" + |Negative | | style="background:#F5F5F5;" align="center" + |<nowiki> style="background:#F5F5F5;" align="center" + |Negative</nowiki> | ||
| style="background:#F5F5F5;" align="center" + | + | | style="background:#F5F5F5;" align="center" + | + | ||
| style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> | | style="background:#F5F5F5;" align="center" + |<nowiki>+</nowiki> |
Latest revision as of 18:50, 19 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Flow chart
Approach to muscle weakness[1][2]
Objective Muscle weakness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Malignancy Arthralgia Anemia Firbomyalgia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Generalized | Localized | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Myasthenia gravis Periodic paralysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymmetric | Symmetric | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cerebrovascular accidents Demyleinating disorders Atrophy Mononeuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Specific pattern | Specific pattern | Proximal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hereditary neuropathy Muscular dystrophy | Myoapthy Duchenne muscular dystrophy | Motor neuron disease Peripheral neuropathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating Various Muscle Weakness
Organ system | Disease | Symptoms | History | Physical
Examination |
Diagnosis | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |||||
Medication−induced | Corticosteroids[3] | Variable | Proximal | − | + | − | − | − | + | − | − |
|
|
|
|
|
|
| |
Statins[4] | 60+ | Proximal | − | + | − | − | − | − | − | −/+(Rhabdomyolysis) |
|
|
|
|
|
|
| ||
Alcohol[5] | Variable | Proximal | − | − | − | + | +/− | − | − | − |
|
|
|
|
|
| |||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Endocrine | Cushing's disease[6] | 25 −45 | Proximal | − | − | − | − | − | + | − | − |
|
|
|
|
|
|
Normal | |
Adrenal insufficiency[7] | 30−50 years | Proximal | − | + | − | − | − | − | + | − |
|
|
|
|
|
| |||
Hyperaldosteronism with myopathy[8] | 50 | Proximal & distal |
− | − | − | − | − | − | − | + |
|
|
|
| |||||
Hyperthyroidism[9] | 40 | Proximal | − | − | − | − | − | + | + | + |
|
|
|
|
|
||||
Hypothyroidism[10] | 55 | Proximal | − | + | + | − | − | + | + | + Rhabdomyolysis |
|
|
|
|
|
|
| ||
Diabetic infraction[11] | 45 | Proximal | + | + | − | − | + | + | − | − |
|
|
|
| |||||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Inflammatory/ Rheumatologic | Dermatomyositis[12] | 40s−50s Can affect children |
Proximal | + | + | − | − | − | − | + | − |
|
|
|
|||||
Polymyositis[13] | > 18 years | Proximal | + | + | − | − | − | − | + | − |
|
|
|
|
| ||||
Inclusion body myositis[14] | 50s | Proximal & distal |
− | − | − | − | − | − | − | − |
|
|
|
|
|
|
|||
Fibromyalgia[15] | 40−50s | Generalized | − | − | − | − | + | − | − | − |
|
|
|
|
|
|
| ||
Polymyalgia Rheumatica[16] | 50s | Diffuse | + | + | − | − | − | − | + | − |
|
|
|
|
| ||||
Necrotizing autoimmune myopathy | 30-70 | Proximal & distal |
|
|
|||||||||||||||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Genetic | Becker muscular dystrophy[17] | <13yrs | Proximal | − | − | + | + | − | + | − | − |
|
|
|
|
|
|
||
Duchenne muscular dystrophy[18] | <13 yrs | Proximal | − | − | + | + | − | + | − | − |
|
|
|
|
| ||||
Limb−girdle muscular dystrophies[19] | <15 yrs | Proximal | − | + | + | + | − | + | − | − |
|
|
|
|
|
|
|||
Myotonic dystrophy[20] | <18 years | Proximal & distal |
− | − | + | + | − | − | + | − |
|
|
|
|
|
|
|||
Glycogen storage disease[21] | Variable | Proximal | − | − | − | − | − | + | − | − |
|
|
|
| |||||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Infectious | Lyme disease[22] | Variable | Proximal | + | + | − | +/− | + | − | − | − |
|
|
|
|
|
|
| |
Influenza[23] | Variable | style="background:#F5F5F5;" align="center" + |Negative | + | + | − | + | − | − | − | + |
|
|
|
|
|
|
| ||
Polio[24] | <5 yrs | Proximal | − | − | − | + | + | + | − | − |
|
|
|
|
|
|
| ||
Syphilis[25] | Variable | Negative | − | − | − | + | + | − | − | − |
|
|
|
|
|
|
| ||
Pyomyositis[26] | Variable | Proximal & Distal |
+ | + | − | − | − | − | + | − |
|
|
|
|
| ||||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Neurologic | ALS[27] | >35 | Proximal & Distal
|
− | − | − | − | + | + | + | − |
|
|
|
|
|
| ||
Stroke[28] | >65 | Proximal & distal |
− | − | − | + | + | + | − | − |
|
|
|
|
|
|
| ||
GBS[29] | 18 −350 | Proximal | − | − | − | + | − | − | + | − |
|
|
|
|
|
| |||
Multiple Sclerosis[30] | 30's | Proximal & distal |
− | − | − | + | + | − | − | − |
|
|
|
|
|
|
| ||
Organ system | Disease | Age of onset | Muscle weakness | Fever | Myalgia | Contractures | Gait abnormality | Neuropathy | Atrophy | Stiffness | Myoglobinuria | Other features | History | Physical
Examination |
Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |
Neuromuscular | Botulinum[31] | Variable | Distal | − | − | − | + | − | − | + | − |
|
|
|
|
|
|
| |
Lambert−Eaton syndrome[32] | Variable | Distal | − | − | + | + | − | − | + | − |
|
|
| ||||||
Myasthenia gravis[33] | Variable | Proximal | − | − | + | + | − | − | + | − |
|
|
References
- ↑ Jackson CE (April 2008). "A clinical approach to muscle diseases". Semin Neurol. 28 (2): 228–40. doi:10.1055/s-2008-1062266. PMID 18351524.
- ↑ LoVecchio F, Jacobson S (August 1997). "Approach to generalized weakness and peripheral neuromuscular disease". Emerg. Med. Clin. North Am. 15 (3): 605–23. PMID 9255135.
- ↑ Gupta A, Gupta Y (September 2013). "Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment". Indian J Endocrinol Metab. 17 (5): 913–6. doi:10.4103/2230-8210.117215. PMC 3784879. PMID 24083177.
- ↑ Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ (2011). "Statin-induced myopathies". Pharmacol Rep. 63 (4): 859–66. PMID 22001973.
- ↑ Preedy VR, Adachi J, Ueno Y, Ahmed S, Mantle D, Mullatti N, Rajendram R, Peters TJ (November 2001). "Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis". Eur. J. Neurol. 8 (6): 677–87. PMID 11784353.
- ↑ Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK (July 2014). "Myopathies of endocrine disorders: A prospective clinical and biochemical study". Ann Indian Acad Neurol. 17 (3): 298–302. doi:10.4103/0972-2327.138505. PMC 4162016. PMID 25221399.
- ↑ Ruff RL, Weissmann J (August 1988). "Endocrine myopathies". Neurol Clin. 6 (3): 575–92. PMID 3065602.
- ↑ Sambrook MA, Heron JR, Aber GM (April 1972). "Myopathy in association with primary hyperaldosteronism". J. Neurol. Neurosurg. Psychiatry. 35 (2): 202–7. PMC 494037. PMID 5037033.
- ↑ Li Q, Liu Y, Zhang Q, Tian H, Li J, Li S (July 2017). "Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report". Medicine (Baltimore). 96 (30): e7591. doi:10.1097/MD.0000000000007591. PMC 5627834. PMID 28746208.
- ↑ Khaleeli AA, Griffith DG, Edwards RH (September 1983). "The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle". Clin. Endocrinol. (Oxf). 19 (3): 365–76. PMID 6627693.
- ↑ Horton WB, Taylor JS, Ragland TJ, Subauste AR (2015). "Diabetic muscle infarction: a systematic review". BMJ Open Diabetes Res Care. 3 (1): e000082. doi:10.1136/bmjdrc-2015-000082. PMC 4410119. PMID 25932331.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Ohara N, Katada S, Yamada T, Mezaki N, Suzuki H, Suzuki A, Hanyu O, Yoneoka Y, Kawachi I, Shimohata T, Kakita A, Nishizawa M, Sone H (2016). "Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism". Intern. Med. 55 (21): 3185–3190. doi:10.2169/internalmedicine.55.5926. PMC 5140872. PMID 27803417.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.
- ↑ Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.
- ↑ Flanigan KM (August 2014). "Duchenne and Becker muscular dystrophies". Neurol Clin. 32 (3): 671–88, viii. doi:10.1016/j.ncl.2014.05.002. PMID 25037084.
- ↑ Guglieri M, Straub V, Bushby K, Lochmüller H (October 2008). "Limb-girdle muscular dystrophies". Curr. Opin. Neurol. 21 (5): 576–84. doi:10.1097/WCO.0b013e32830efdc2. PMID 18769252.
- ↑ Udd B, Krahe R (October 2012). "The myotonic dystrophies: molecular, clinical, and therapeutic challenges". Lancet Neurol. 11 (10): 891–905. doi:10.1016/S1474-4422(12)70204-1. PMID 22995693.
- ↑ Kannourakis G (April 2002). "Glycogen storage disease". Semin. Hematol. 39 (2): 103–6. PMID 11957192.
- ↑ Schoenen J, Sianard-Gainko J, Carpentier M, Reznik M (August 1989). "Myositis during Borrelia burgdorferi infection (Lyme disease)". J. Neurol. Neurosurg. Psychiatry. 52 (8): 1002–5. PMC 1031843. PMID 2795056.
- ↑ Bove KE, Hilton PK, Partin J, Farrell MK (1983). "Morphology of acute myopathy associated with influenza B infection". Pediatr Pathol. 1 (1): 51–66. PMID 6687269.
- ↑ Howard RS (June 2005). "Poliomyelitis and the postpolio syndrome". BMJ. 330 (7503): 1314–8. doi:10.1136/bmj.330.7503.1314. PMC 558211. PMID 15933355.
- ↑ French P (January 2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.
- ↑ Crum NF (September 2004). "Bacterial pyomyositis in the United States". Am. J. Med. 117 (6): 420–8. doi:10.1016/j.amjmed.2004.03.031. PMID 15380499.
- ↑ Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015). "A comprehensive review of amyotrophic lateral sclerosis". Surg Neurol Int. 6: 171. doi:10.4103/2152-7806.169561. PMC 4653353. PMID 26629397.
- ↑ Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S (May 2010). "Acute ischemic stroke update". Pharmacotherapy. 30 (5): 493–514. doi:10.1592/phco.30.5.493. PMID 20412000.
- ↑ van Doorn PA (June 2013). "Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)". Presse Med. 42 (6 Pt 2): e193–201. doi:10.1016/j.lpm.2013.02.328. PMID 23628447.
- ↑ Goldenberg MM (March 2012). "Multiple sclerosis review". P T. 37 (3): 175–84. PMC 3351877. PMID 22605909.
- ↑ Cherington M (June 2004). "Botulism: update and review". Semin Neurol. 24 (2): 155–63. doi:10.1055/s-2004-830901. PMID 15257512.
- ↑ Titulaer MJ, Lang B, Verschuuren JJ (December 2011). "Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies". Lancet Neurol. 10 (12): 1098–107. doi:10.1016/S1474-4422(11)70245-9. PMID 22094130.
- ↑ Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J (2012). "Myasthenia gravis: a review". Autoimmune Dis. 2012: 874680. doi:10.1155/2012/874680. PMC 3501798. PMID 23193443.